Heart Disease Etiology Impacts Catheter Ablation Outcomes
By HospiMedica International staff writers Posted on 19 Jan 2016 |
A new study reveals that cardiomyopathy etiology impacts the long term outcomes of catheter ablation procedures.
Researchers at Alfred Hospital (Melbourne, Australia), St. Bartholomew's Hospital (London, United Kingdom), and other institutions conducted a study to examine the impact of cardiomyopathy etiology on long-term outcomes of catheter ablation in 101 patients between 2002 and 2014. The patients suffered from known heart disease (KHD; 77 patients) and idiopathic dilated cardiomyopathy (IDCM; 24 patients). All patients had a left ventricular ejection fraction (LVEF) lower than 45%.
The results showed that at three-year follow-up, the IDCM group showed less functional impairment and improved LVEF than the KHD group. Super responders, with an ejection fraction improvement of more than 15%, were overwhelmingly found in the IDCM group, and demonstrated greater AF control. The IDCM group also had significantly less all-cause mortality (1.3%) than the KHD group (17%). The study was published online on December 28, 2015, in the Journal of Cardiovascular Electrophysiology.
“Idiopathic dilated cardiomyopathy was associated with greater AF control and improvement in symptoms and LVEF, compared to patients with known heart disease post AF ablation,” concluded lead author Sandeep Prabhu, MD, MBBS, of the Alfred Hospital, and colleagues. “AF is an important reversible cause of heart failure in patients with an unexplained cardiomyopathy, and catheter ablation is an effective treatment option.”
AF is a medical condition that can lead to serious adverse events, such as thrombi travelling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage. AF affects an estimated one percent of the population, with nearly three million AF patients in the United States and six million AF patients in Europe.
Related Links:
Alfred Hospital
St. Bartholomew's Hospital
Researchers at Alfred Hospital (Melbourne, Australia), St. Bartholomew's Hospital (London, United Kingdom), and other institutions conducted a study to examine the impact of cardiomyopathy etiology on long-term outcomes of catheter ablation in 101 patients between 2002 and 2014. The patients suffered from known heart disease (KHD; 77 patients) and idiopathic dilated cardiomyopathy (IDCM; 24 patients). All patients had a left ventricular ejection fraction (LVEF) lower than 45%.
The results showed that at three-year follow-up, the IDCM group showed less functional impairment and improved LVEF than the KHD group. Super responders, with an ejection fraction improvement of more than 15%, were overwhelmingly found in the IDCM group, and demonstrated greater AF control. The IDCM group also had significantly less all-cause mortality (1.3%) than the KHD group (17%). The study was published online on December 28, 2015, in the Journal of Cardiovascular Electrophysiology.
“Idiopathic dilated cardiomyopathy was associated with greater AF control and improvement in symptoms and LVEF, compared to patients with known heart disease post AF ablation,” concluded lead author Sandeep Prabhu, MD, MBBS, of the Alfred Hospital, and colleagues. “AF is an important reversible cause of heart failure in patients with an unexplained cardiomyopathy, and catheter ablation is an effective treatment option.”
AF is a medical condition that can lead to serious adverse events, such as thrombi travelling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage. AF affects an estimated one percent of the population, with nearly three million AF patients in the United States and six million AF patients in Europe.
Related Links:
Alfred Hospital
St. Bartholomew's Hospital
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery